Pfizer’s Eucrisa Approval By FDA Adds New Dermatology Anchor

Pfizer’s Eucrisa is one of the first new drugs to launch for the treatment of atopic dermatitis in more than a decade. The launch reflects an expansion strategy by Pfizer to move into a new therapeutic area – dermatology.